| Breakdown | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.52B | 1.36B | 1.20B | 1.01B | 787.40M |
| Gross Profit | 377.70M | 628.90M | 261.00M | 335.30M | 288.40M |
| EBITDA | 368.60M | 296.10M | 254.00M | 203.50M | 138.40M |
| Net Income | 184.90M | 129.30M | 117.70M | 94.70M | 69.80M |
Balance Sheet | |||||
| Total Assets | 1.86B | 1.77B | 1.59B | 1.39B | 994.00M |
| Cash, Cash Equivalents and Short-Term Investments | 81.70M | 55.50M | 62.40M | 41.70M | 24.80M |
| Total Debt | 464.90M | 552.10M | 397.30M | 439.70M | 254.50M |
| Total Liabilities | 862.60M | 877.40M | 687.30M | 721.50M | 453.00M |
| Stockholders Equity | 989.70M | 888.00M | 895.60M | 662.00M | 536.30M |
Cash Flow | |||||
| Free Cash Flow | 253.20M | 178.40M | 166.10M | 109.60M | 109.90M |
| Operating Cash Flow | 267.60M | 198.10M | 189.20M | 125.00M | 116.10M |
| Investing Cash Flow | -31.30M | -294.80M | -270.90M | -172.20M | -447.70M |
| Financing Cash Flow | -212.90M | 90.30M | 107.50M | 64.70M | 139.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £2.64B | 8.02 | 11.47% | 3.58% | -2.44% | -6.43% | |
73 Outperform | £7.87B | 38.47 | 14.17% | 1.13% | 11.82% | 42.93% | |
64 Neutral | £190.95M | 0.64 | 7.92% | 6.53% | ― | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
50 Neutral | £36.47M | -10.98 | -64.09% | ― | -0.25% | -84.33% | |
47 Neutral | £98.33M | -1.82 | -47.73% | ― | -2.08% | -9.83% |